- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03366441
Reactivation of Inactive Blood Donors
November 9, 2018 updated by: OUYANG Jian, Guangzhou Blood Center
Effective Methods for Reactivating Inactive Blood Donors: a Stratified Randomized Controlled Study
Blood donor retention is a critical strategy to ensure the safety and sufficiency of clinical blood supply.
An effective strategy can prevent donors from lapsing and eventually becoming inactive.
Study Overview
Study Type
Interventional
Enrollment (Actual)
11880
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510095
- Guangzhou Blood Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Donated blood at least once between Januanry 1 to September 30 2016, and the blood test result is qualified.
Exclusion Criteria:
- Having donated again before intervened.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telephone group
The telephone group received telephone calls.
All non-response and refusing donors were included for further follow-up.
Donors who answered the phone call and agreed to be interviewed were asked the reasons why they had stopped donating according to a pre-designed questionnaire.
All of the responsed donors were re-recruited by altruistic appeal.
|
From 20 October to 10 November 2016, telephone calls were given to the donors in the phone call group
|
Experimental: SMS group
The SMS intervention group received the following text message:"Dear donors, Thank you for your donation through which your love brought hope to those helpless patients and your donated blood reignited the fire in their lives.
If you can, please consider donating blood again to save a life.
Thank you again for your support!" .
All donors either receiving or not receiving the message were included for further follow-up.
|
Text messages were sent to an equal number of donors in the SMS group
|
No Intervention: Control group
No intervention will be giving to this group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood donation rate
Time Frame: 1 year
|
Number of blood donors donate blood again divided by the number of participants in every group after intervened.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-deferral reasons of not donating
Time Frame: 1 day
|
The reasons of not donating again in the telephone group.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2016
Primary Completion (Actual)
November 10, 2017
Study Completion (Actual)
December 5, 2017
Study Registration Dates
First Submitted
December 4, 2017
First Submitted That Met QC Criteria
December 4, 2017
First Posted (Actual)
December 8, 2017
Study Record Updates
Last Update Posted (Actual)
November 14, 2018
Last Update Submitted That Met QC Criteria
November 9, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- Guangzhou Blood Center
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Donor
-
Guangzhou Blood CenterCompleted
-
Haemonetics CorporationCompletedTransmission, Blood, Recipient/DonorUnited States
-
Haemonetics CorporationCompletedTransmission, Blood, Recipient/DonorUnited States
-
Haemonetics CorporationCompletedTransmission, Blood, Recipient/DonorUnited States
-
Haukeland University HospitalCompletedAutologous Blood Transfusion | Physical Performance | Donor SafetyNorway
-
Oslo University HospitalUniversity of Oslo; South-Eastern Norway Regional Health AuthorityCompletedRenal Transplant Donor of Left Kidney | Renal Transplant Donor of Right KidneyNorway
-
University of Maryland, BaltimoreCompletedRobotic Surgery | Renal Transplant Donor of Left Kidney | Donor Nephrectomy | Single-portUnited States
-
Guangzhou Blood CenterCompleted
-
Guangzhou Blood CenterCompleted
-
Radboud University Medical CenterMerck Sharp & Dohme LLCCompletedSurgery | Neuromuscular Block | Renal Transplant Donor of Left Kidney | Renal Transplant Donor of Right KidneyNetherlands
Clinical Trials on Telephone call
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Swansea UniversityAbertawe Bro Morgannwg University Health BoardRecruitingPelvic Floor DysfunctionsUnited Kingdom
-
University of CopenhagenRecruitingWisdom TeethDenmark
-
Maimonides Medical CenterCompletedParkinson Disease | Alzheimer Disease | DysphagiaUnited States
-
Groupe Hospitalier Diaconesses Croix Saint-SimonRecruitingHip Arthropathy Associated With Other ConditionsFrance
-
University Hospital, AngersCompletedPseudoxanthoma Elasticum | EmploymentFrance
-
Xuanwu Hospital, BeijingRecruiting
-
University Hospitals Cleveland Medical CenterCompleted
-
Boston Urogynecology AssociatesHarvard UniversityCompletedUrinary Bladder, Overactive | Lower Urinary Tract Symptoms | Urinary IncontinenceUnited States
-
Norwegian Institute of Public HealthNot yet recruitingCancer Colorectal